PMC:7755033 / 81175-81380 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1434","span":{"begin":133,"end":145},"obj":"Chemical"},{"id":"1435","span":{"begin":190,"end":201},"obj":"Chemical"}],"attributes":[{"id":"A1435","pred":"tao:has_database_id","subj":"1435","obj":"MESH:D054358"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Kinase inhibitor (KI) Nuclear receptor ligand (NRL) Protease inhibitor (PI) Enzymeinhibitor (EI)  \n                 \n1. Withaferin A 0.07 0.14 –0.49 0.76 0.15 0.94  \n2. Withanolide A "}

{"project":"LitCovid-sentences","denotations":[{"id":"T799","span":{"begin":103,"end":128},"obj":"Sentence"},{"id":"T800","span":{"begin":129,"end":131},"obj":"Sentence"},{"id":"T801","span":{"begin":133,"end":185},"obj":"Sentence"},{"id":"T802","span":{"begin":186,"end":188},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Kinase inhibitor (KI) Nuclear receptor ligand (NRL) Protease inhibitor (PI) Enzymeinhibitor (EI)  \n                 \n1. Withaferin A 0.07 0.14 –0.49 0.76 0.15 0.94  \n2. Withanolide A "}